Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Net Medical Xpress Solutions (OTCPK:NMXS) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Net Medical Xpress Solutions EBITDA Margin % Related Terms
Net Medical Xpress Solutions EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Net Medical Xpress Solutions EBITDA Margin % Chart
NMXS vs TVMD, UCBB, ESSI: EBITDA Margin % Comparison
For the Health Information Services subindustry, Net Medical Xpress Solutions's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Net Medical Xpress Solutions EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Net Medical Xpress Solutions's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Net Medical Xpress Solutions's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Net Medical Xpress Solutions (NMXS) has a EBITDA Margin % of 2.93% as of Jun. 2018. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Net Medical Xpress Solutions and its competitors.
Is Net Medical Xpress Solutions' EBITDA Margin % too high?
Net Medical Xpress Solutions' current EBITDA Margin % is 2.93%. The Healthcare Providers & Services industry median EBITDA Margin % is 10.23. Net Medical Xpress Solutions' value of 2.93% is 71.4% below this industry median.
How does Net Medical Xpress Solutions' EBITDA Margin % compare to TVMD and UCBB?
Net Medical Xpress Solutions' EBITDA Margin % of 2.93% can be compared against companies in the Healthcare Providers & Services industry. The industry median EBITDA Margin % is 10.23. Net Medical Xpress Solutions' value of 2.93% is 71.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.23, based on 663 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Net Medical Xpress Solutions's current EBITDA Margin % of 2.93% is 71.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Net Medical Xpress Solutions and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Net Medical Xpress Solutions's current EBITDA Margin % is 2.93%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Net Medical Xpress Solutions stock overvalued right now?
Net Medical Xpress Solutions (NMXS) has a current EBITDA Margin % of 2.93%. The current EBITDA Margin % is 2.93% and 71.4% below the Healthcare Providers & Services industry median of 10.23. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Net Medical Xpress Solutions (NMXS), the current EBITDA Margin % is 2.93% as of Jun. 2018. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Net Medical Xpress Solutions Inc is engaged in providing solutions to the telemedicine industry which deliver medical laboratory services. It offers proprietary software that links electronic medical records while enabling state-of-the-art conferencing and communications. The company's mobile fleet of vans is utilized to provide sales support for its clinical research organization. It also offers call centers, proprietary hardware implementations, diagnostic and clinical services, and software research and development capabilities.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NMXS has been successfully added to your 
